VYCOR MEDICAL INC

VYCO

VYCOR MEDICAL INC

VYCO

Insider Sentiment (TTM):

Last Purchase:2014-12-31Last Sale:2014-07-01Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2017-12-31Institutional Shares Owned:500Shares Outstanding:19,821,988Institutional Ownership Pct.:0.00%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	0	0	0	0	0	0	0	0	0	0	0	0
Accounts Receivable Net Current	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current
Assets Current	1	1	1	1	1	1	1	1	1	1	1	1
Inventory Net	0	0	0	0	0	0	0	0	0	0	0	0
Prepaid Expense And Other Assets Current	0	0	0	0	0	0	0	0	0	0	0	0
Assets Of Disposal Group Including Discontinued Op…	0	-	0	0	0	0	0	0	0	0	0	0
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Intangible And Other Asse…
Inventory Noncurrent	0	0	0	0	0	0	0	-	-	-	-	-
Security Deposit	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets
Other Assets	0	0	0	0	0	0	0	-	-	-	0	-
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Assets	1	1	1	1	1	1	1	1	1	1	1	1
Liabilities And Stockhold…
Accounts Payable Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current
Liabilities Current	5	5	5	5	5	5	4	5	4	4	4	4
Accrued Liabilities Current	0	0	0	0	-	-	0	-	-	-	-	-
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Liability Noncurrent	-	-	-	0	0	0	0	0	0	0	0	0
Long Term Loans From Bank	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities	5	5	5	5	5	5	5	5	5	4	4	4
Preferred Stock Value	-	-	-	-	-	-	-	-	-	-	-	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Treasury Stock Value	-	-	-	-	-	-	-0	-0	-0	-0	-0	-0
Additional Paid In Capital	29	29	29	29	29	29	29	29	29	29	29	29
Stockholders Equity
Stockholders Equity	-4	-4	-4	-4	-4	-4	-4	-4	-4	-4	-3	-3
Treasury Stock Common Value	-0	-0	-0	-0	-0	-0	-0	-	-	-	-	-
Retained Earnings Accumulated Deficit	-34	-34	-34	-34	-33	-33	-33	-33	-33	-33	-33	-33
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities And Stockholders Equity	1	1	1	1	1	1	1	1	1	1	1	1
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	-	-	-	-	-	-	-	-	-	-	-	0
Preferred Stock Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	55	55	55	55	55	55	55	55	55	55	55	55
Common Stock Shares Issued	33	33	33	33	33	33	33	33	33	33	33	33
Shares Outstanding	33	33	33	33	33	33	33	33	33	33	33	33
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-1.43%	-10.00%	-1.43%	-	-	-	-	-	-	-	-	-
2025	-21.85%	-12.58%	-13.91%	17.27%	59.09%	36.36%	13.14%	-30.86%	-37.14%	-22.22%	-22.22%	-26.67%
2024	7.14%	7.14%	4.76%	-7.35%	14.71%	14.71%	-11.36%	-20.45%	-21.59%	123.53%	73.53%	94.12%
2023	-	-	-	-	-	-	-17.65%	2.35%	0.00%	0.00%	7.14%	7.14%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.13	0.13	0.12	0.14	0.12	0.13	0.14	0.16	0.15	0.14	0.14	0.16
Quick Ratio	0.07	0.07	0.06	0.08	0.07	0.06	0.08	0.09	0.09	0.07	0.07	0.08
Working Capital	-4.29M	-4.30M	-4.22M	-4.15M	-4.03M	-4.05M	-3.88M	-3.81M	-3.66M	-3.67M	-3.49M	-3.41M
Leverage & Debt
Debt to Equity	-1.19	-1.20	-1.20	-1.23	-1.23	-1.24	-1.27	-1.29	-1.28	-1.28	-1.30	-1.33
Interest Coverage TTM	1.28	1.84	0.67	1.79	0.45	-0.25	-0.18	-1.86	-1.67	-0.05	0.81	0.27
Debt Ratio	6.23	5.95	5.92	5.28	5.40	5.14	4.70	4.43	4.54	4.63	4.35	4.07
Efficiency & Turnover
Asset Turnover TTM	2.14	2.10	2.04	1.89	1.90	1.77	1.60	1.35	1.43	1.59	1.58	1.42
Days Sales Outstanding TTM	40.90	40.99	45.46	54.20	46.73	51.17	52.88	62.50	71.83	53.61	46.41	55.87
Receivables Turnover TTM	8.92	8.91	8.03	6.73	7.81	7.13	6.90	5.84	5.08	6.81	7.86	6.53
Per Share Metrics
Diluted EPS TTM	-0.01	-0.01	-0.01	-0.00	-0.00	-0.00	-0.00	-0.00	-0.01	-0.00	-0.00	-0.01
Free Cash Flow Per Share TTM	0.00	0.00	-0.00	-0.00	-0.00	0.00	0.00	0.00	0.00	-0.00	0.00	-0.00
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	83.37%	83.67%	83.78%	85.35%	85.75%	87.70%	89.50%	89.53%	89.23%	89.48%	90.08%	90.16%
Operating Profit Margin TTM	2.67%	4.91%	1.82%	4.72%	1.27%	-0.74%	-0.58%	-6.42%	-6.09%	-0.18%	2.75%	0.92%
Net Profit Margin TTM	-12.29%	-9.33%	-21.29%	-0.87%	-4.57%	-6.82%	-6.75%	-2.17%	-13.65%	-7.46%	-4.77%	-17.94%
Growth Metrics
Net Revenue Growth (1Y)	1.61%	11.66%	17.24%	31.85%	30.79%	17.55%	8.81%	1.32%	-4.55%	13.10%	19.43%	16.17%
Net Income Growth (1Y)	173.44%	52.79%	270.15%	-47.41%	-56.24%	7.46%	53.82%	-87.73%	-41.68%	-77.94%	-82.79%	-68.07%
EPS Growth (1Y)	173.44%	52.79%	264.73%	-48.15%	-57.21%	5.06%	52.51%	-87.83%	-41.68%	-78.00%	-83.26%	-68.69%
Valuation Metrics
P/E TTM	-9.92	-17.07	-10.18	-354.45	-54.23	-18.84	-21.47	-81.91	-15.82	-28.32	-36.02	-12.14
P/B TTM	-0.52	-0.71	-0.99	-1.45	-1.14	-0.56	-0.62	-0.70	-0.83	-0.86	-0.75	-0.96
P/S TTM	1.22	1.59	2.17	3.07	2.48	1.28	1.45	1.78	2.16	2.11	1.72	2.18
Market Cap	2.20M	3.00M	4.04M	5.84M	4.41M	2.17M	2.30M	2.57M	2.94M	3.03M	2.51M	3.10M
Enterprise Value	2.04M	2.83M	3.95M	5.78M	4.31M	2.11M	2.20M	2.41M	2.82M	2.99M	2.45M	3.03M
Calculated Values
Free Cash Flow TTM	59.78K	107.64K	-18.70K	-94.61K	-17.08K	25.94K	54.74K	92.63K	69.18K	-2.69K	20.04K	-13.24K
Net Debt	-158.91K	-173.63K	-86.98K	-64.23K	-99.70K	-61.05K	-105.65K	-157.63K	-119.30K	-43.86K	-57.29K	-69.06K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2014-12-31Purchase

Owner: Fountainhead, Capital Man…

Title: -

Shares: 8,380

Price/Share: $1.79

Value: $15,000.20

Shares Owned: 4,366,844

Relationship: TenPercentOwner

Ownership: Direct

2014-10-06Purchase

Owner: Fountainhead, Capital Man…

Title: -

Shares: 6,383

Price/Share: $2.35

Value: $15,000.05

Shares Owned: 2,358,464

Relationship: TenPercentOwner

Ownership: Direct

2014-08-05Purchase

Owner: Fountainhead, Capital Man…

Title: -

Shares: 164,149

Price/Share: $10.00

Value: $1,641,490.00

Shares Owned: 164,149

Relationship: TenPercentOwner

Ownership: Direct

2014-07-01Sale

Owner: Bronsther, Oscar

Title: -

Shares: 6,241

Price/Share: $2.75

Value: $17,162.75

Shares Owned: 18,216

Relationship: Director

Ownership: Direct

2014-06-30Purchase

Owner: Fountainhead, Capital Man…

Title: -

Shares: 6,329

Price/Share: $1.80

Value: $11,392.20

Shares Owned: 4,352,081

Relationship: TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2014-12-31	Fountainhead, Capital Man…	TenPercentOwner	-	Direct	Purchase	8,380	1.79	$15,000.20	4,366,844	4
2014-10-06	Fountainhead, Capital Man…	TenPercentOwner	-	Direct	Purchase	6,383	2.35	$15,000.05	2,358,464	4
2014-08-05	Fountainhead, Capital Man…	TenPercentOwner	-	Direct	Purchase	164,149	10.00	$1,641,490.00	164,149	4
2014-07-01	Bronsther, Oscar	Director	-	Direct	Sale	6,241	2.75	$17,162.75	18,216	4
2014-06-30	Fountainhead, Capital Man…	TenPercentOwner	-	Direct	Purchase	6,329	1.80	$11,392.20	4,352,081	4
2014-03-31	Fountainhead, Capital Man…	TenPercentOwner	-	Direct	Purchase	6,276	1.80	$11,296.80	4,343,996	4
2014-01-02	Fountainhead, Capital Man…	TenPercentOwner	-	Direct	Purchase	792,523	1.80	$1,426,541.40	4,337,720	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2017-12-31

0.00%

Inst. Shares: 500

Shares Outstanding: 19,821,988

2017-09-30

0.00%

Inst. Shares: 500

Shares Outstanding: 19,738,189

2017-06-30

0.00%

Inst. Shares: 500

Shares Outstanding: 19,708,401

2017-03-31

0.00%

Inst. Shares: 500

Shares Outstanding: 17,585,443

2016-12-31

0.00%

Inst. Shares: 500

Shares Outstanding: 11,336,023

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2017-12-31	500	19,821,988	0.00%
2017-09-30	500	19,738,189	0.00%
2017-06-30	500	19,708,401	0.00%
2017-03-31	500	17,585,443	0.00%
2016-12-31	500	11,336,023	0.00%
2016-09-30	500	11,220,856	0.00%
2016-06-30	500	11,054,735	0.00%
2016-03-31	500	10,962,845	0.00%
2015-12-31	500	10,929,226	0.00%
2015-09-30	500	10,884,962	0.00%
2015-06-30	500	10,838,449	0.00%
2015-03-31	500	10,811,062	0.00%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

VYCOR MEDICAL INC (VYCO) — SEC Financial Statements & Analysis

VYCOR MEDICAL INC (VYCO) is a surgical & medical instruments & apparatus company, incorporated in DE. VYCOR MEDICAL INC trades on OTC as: VYCO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), VYCOR MEDICAL INC reported a 1.61% year-over-year revenue growth, a Gross Profit Margin of 83.37% (TTM), a Debt-to-Equity ratio of -1.19x, a Price-to-Sales (P/S) ratio of 1.22x (TTM), a Price-to-Book (P/B) ratio of -0.52x (TTM), at a market cap of $2.20M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 1.61%
Gross Profit Margin TTM: 83.37%
Debt To Equity: -1.19x
P/S TTM: 1.22x
P/B TTM: -0.52x
Market Cap: $2.20M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is VYCOR MEDICAL INC in?

VYCOR MEDICAL INC (VYCO) operates in the Surgical & Medical Instruments & Apparatus industry.

What is VYCO's market cap?

VYCOR MEDICAL INC (VYCO) has a market capitalization of $2.20M as of 2026-06-30.

What exchange does VYCO trade on?

VYCOR MEDICAL INC (VYCO) trades on the OTC.

Where is VYCOR MEDICAL INC incorporated?

VYCOR MEDICAL INC is incorporated in DE.